Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/1999
03/23/1999US5885962 Stem cell factor analog compositions and method
03/23/1999US5885835 Kit for in vitro cell growth of eucaryotes using low molecular weight peptides containing L-glutamine
03/23/1999US5885833 Nucleic acid constructs for the cell cycle-regulated expression of genes and therapeutic methods utilizing such constructs
03/23/1999US5885832 Human lens epithelial cell line
03/23/1999US5885830 Anti-ribonucleotide reductase R2 subunit monoclonal antibody
03/23/1999US5885829 Growing viable oral tissue cells on a synthetic matrix in vitro under conditions effective and for a period of time sufficient to allow proliferation of viable oral tissue cells
03/23/1999US5885826 Useful to produce chemicals either intracellularly or extracellulary in a magnetofluidized bed bioreactor
03/23/1999US5885823 Bacteria strain atcc no.55783 are incubated in an oxygen concentration of from about 0 percent to about 18 percent, agitating the bacteria in suspension; veterinary medicine
03/23/1999US5885818 Culturing a host cell transformed with genetic engineered dna vector under conditions suitable for expression of agei restriction endonucleases
03/23/1999US5885802 High methionine derivatives of α-hordothionin
03/23/1999US5885801 Protein enriched in threonine residues which can be expressed in plants used for foods or animal feeds
03/23/1999US5885795 Methods of expressing angiostatic protein
03/23/1999US5885777 A nucleotide sequence encoding an active phosphatidylinositol-3-kinase consisting of specific amino acid sequences or a nucleotide sequence which hybridizes with above nucleotide sequences after washing in low salt buffer
03/23/1999US5885575 Diagnosis and therapy of tumour metastases
03/23/1999US5885574 Antibodies which activate an erythropoietin receptor
03/23/1999US5885572 Administering polypeptide or active fragment to treat bacterial infections
03/23/1999US5885571 Bacillus thuringiensis strains and their insecticidal proteins
03/23/1999CA2140910C An improved method of agrobacterium-mediated transformation of cultured soybean cells
03/23/1999CA2011230C Mass production of artificial seed potatoes (potato microtubers)
03/23/1999CA1340461C Alveolar surfactant proteins
03/23/1999CA1340456C Chimeric rodent/human immunoglobulins specific for tumor-associated antigens
03/22/1999CA2244237A1 A human lig-1 homolog (hlig-1)
03/19/1999CA2216055A1 A medium to promote islet cell survival
03/19/1999CA2211003A1 Human tumor necrosis factor receptor
03/18/1999WO1999013090A1 Regulation of protein secretion
03/18/1999WO1999013085A2 MICROBIAL GENES FOR SECRETED β-GLUCURONIDASES, GENE PRODUCTS AND USES THEREOF
03/18/1999WO1999013083A2 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth
03/18/1999WO1999013076A1 Mpl ligand analogs
03/18/1999WO1999013073A2 Viral vector system capable of expressing an apoptosis-associated gene
03/18/1999WO1999013066A1 Secreted proteins and polynucleotides encoding them
03/18/1999WO1999013064A2 Viral infection of cells using viral vectors
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999013054A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999WO1999012975A1 Smart polymer-coupled bioactive entities and uses thereof
03/18/1999WO1999012974A1 Monoclonal antibodies that bind testosterone
03/18/1999WO1999012973A1 Monoclonal antibody inducing apoptosis
03/18/1999WO1999012972A1 Monoclonal antibody against human monocytes
03/18/1999WO1999012971A2 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
03/18/1999WO1999012965A2 April- a novel protein with growth effects
03/18/1999WO1999012964A2 Kay - a novel immune system protein
03/18/1999WO1999012574A1 Improvements in or relating to expression of immunogenic substances
03/18/1999WO1999012573A1 Improvements in or relating to regulation of t cell activation
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012557A1 Novel prokaryotic polynucleotides, polypeptides and their uses
03/18/1999WO1999012555A1 Galactosidase modified submucosal tissue
03/18/1999WO1999012554A1 Chemical supplementation of bone
03/18/1999WO1999012414A1 Transplacental delivery of oligonucleotides
03/18/1999WO1999000516A3 Neuronal stem cell gene
03/18/1999WO1999000410A3 Human extracellular matrix proteins
03/18/1999WO1998059035A3 Serum-free cell growth medium
03/18/1999WO1998058954A3 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens
03/18/1999WO1998057987A3 Irs-p53h, human insulin receptor tyrosine kinase substrate
03/18/1999WO1998057982A3 Aib1, a steroid receptor co-activator
03/18/1999WO1998056909A3 Secreted proteins and polynucleotides encoding them
03/18/1999WO1998055510A3 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
03/18/1999WO1998053063A3 Mammalian cell transduction for use in gene therapy
03/18/1999WO1998053053A3 Dna encoding an arthropod chitin synthase
03/18/1999WO1998052619A3 Peptide-coated implants and methods for producing same
03/18/1999WO1998046722A9 Direct expression of peptides into culture media
03/18/1999WO1998044103A3 Protein for inhibiting apoptosis
03/18/1999DE19740571C1 Antigen-specific stimulation of T cells
03/18/1999CA2323936A1 Estrogen receptor
03/18/1999CA2303618A1 Improvements in or relating to expression of immunogenic substances
03/18/1999CA2303617A1 Improvements in or relating to regulation of t cell activation
03/18/1999CA2303616A1 Transplacental delivery of oligonucleotides
03/18/1999CA2303615A1 April- a novel protein with growth effects
03/18/1999CA2303480A1 Mpl ligand analogs
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303431A1 Monoclonal antibody against human monocytes
03/18/1999CA2303424A1 Kay - a novel immune system protein
03/18/1999CA2303423A1 Microbial genes for secreted .beta.-glucuronidases, gene products and uses thereof
03/18/1999CA2303347A1 Chemical supplementation of bone
03/18/1999CA2303072A1 Monoclonal antibody inducing apoptosis
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2302705A1 Secreted proteins and polynucleotides encoding them
03/18/1999CA2301830A1 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth
03/18/1999CA2300804A1 Monoclonal antibodies that bind testosterone
03/18/1999CA2300387A1 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999CA2244325A1 Novel amps
03/18/1999CA2244323A1 Novel gapdh
03/17/1999EP0902089A2 Disease resistant plant including thionin gene
03/17/1999EP0902085A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/17/1999EP0901527A2 Regulating metabolism by modifying the level of trehalose-6-phosphate
03/17/1999EP0901524A1 Intracellular antifreeze polypeptides and nucleic acids
03/17/1999EP0901523A1 Immortalized avian cell lines
03/17/1999EP0901522A1 Immortal avian cells
03/17/1999EP0901521A1 Antigenic modulation of cells
03/17/1999EP0901503A1 Synthetic glucagon binding proteins
03/17/1999EP0901384A1 Polysaccharide sponges for cell culture and transplantation
03/17/1999EP0766510B1 Use of a commiphora mukul extract as a pigmenting agent
03/17/1999EP0563296B1 Optimization of binding proteins
03/17/1999CN1211282A Seed shattering
03/17/1999CN1211277A Systems and methods for removing viral agents from blood
03/17/1999CN1211255A Ob receptor and method of diagnosing and treating weight
03/17/1999CN1210866A Preparation of recombinant factor VIII in protein free medium
03/17/1999CA2244330A1 Novel histidine kinase
03/16/1999US5883227 Multiple sclerosis associated polypeptide
03/16/1999US5883226 Nucleotide sequences of genes
03/16/1999US5882929 Biopolymer tissues for prosthesis
03/16/1999US5882928 Culturing mammalian immature oocytes obtained from a mammalian ovary very early in the mammal's menstrual cycle in an oocyte maturation inhibitor-containing culture, removing the inhibitor and maturing and fertilizing the oocytes to produce